Related references
Note: Only part of the references are listed.Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes
Rajesh Katare et al.
CARDIOVASCULAR RESEARCH (2013)
The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells
Karin Albrecht-Schgoer et al.
CIRCULATION (2012)
Use of the mouse aortic ring assay to study angiogenesis
Marianne Baker et al.
NATURE PROTOCOLS (2012)
Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury
Saghir Akhtar et al.
PLOS ONE (2012)
Intravenous Gene Therapy With PIM-1 Via a Cardiotropic Viral Vector Halts the Progression of Diabetic Cardiomyopathy Through Promotion of Prosurvival Signaling
Rajesh Katare et al.
CIRCULATION RESEARCH (2011)
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
Jill Belch et al.
LANCET (2011)
The Emerging Role of the Thioredoxin System in Angiogenesis
Louise L. Dunn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells
Xiaonan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide-Dependent Mechanism
Wilfried Schgoer et al.
CIRCULATION RESEARCH (2009)
Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1α- and basic FGF-dependent pathway in muscle cells
Margot Egger et al.
FASEB JOURNAL (2007)
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial
Y. H. Kusumanto et al.
HUMAN GENE THERAPY (2006)
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease
FC Sasso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2
M Heil et al.
CIRCULATION RESEARCH (2004)
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo
R Kirchmair et al.
CIRCULATION (2004)
Outcomes in patients with diabetes Mellitus undergoing percutaneous coronary intervention in the current era - A report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial
V Mathew et al.
CIRCULATION (2004)
Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis
R Kirchmair et al.
CIRCULATION (2004)
Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro
A Zippo et al.
BLOOD (2004)
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease - A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication
S Rajagopalan et al.
CIRCULATION (2003)
Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF
A Roguin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (Cl-1023) to patients with claudication
S Rajagopalan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery:: A randomized, placebo-controlled, double-blinded phase II study
K Mäkinen et al.
MOLECULAR THERAPY (2002)
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
JA Beckman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications
J Waltenberger
CARDIOVASCULAR RESEARCH (2001)
Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
I Baumgartner et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
